RIVM logo, National Institute for Public Healthe and the Enviroment. Minsty of Health, Welfare and Sport

The National Immunisation Programme in the Netherlands. Developments in 2009

Het Rijksvaccinatieprogramma in Nederland. Ontwikkelingen in 2009

Synopsis

This report gives an update of data on pathogen, epidemiology and adverse events after vaccination in 2008 and the first part of 2009 with regard to diseases included in the current National Immunisation Programme (NIP) and for (potential) new target diseases for which a vaccine is available As a result of the high national vaccination coverage in general, the number of cases of many of the diseases currently covered by the NIP were low in 2008 and 2009. A substantial reduction of severe pneumococcal disease was observed among age groups targeted for pneumococcal vaccination. Despite a somewhat lower incidence of hepatitis B in 2008 compared to 2007, circulation among man having sex with man (MSM) is ongoing. Pertussis occurs regularly with every three years an epidemic. The incidence among adults is increasing but the morbidity remains highest among unvaccinated infants. The measles epidemic of 2008 affecting mostly unvaccinated antroposofic people ended by 2009. In the catch-up campaign for HPV vaccination (starting in March 2009 for girls born in 1993-1996), coverage amounted to 50% for the first dose. The incidence of rotavirus among young children was highest in 2008 since 2000, while the incidence of chickenpox in 2008 was rather low. Furthermore, vaccination of elderly (70+) against herpes zoster may be cost-effective. These data should be used in the advice to the minister regarding potential inclusion into the NIP.
 

Home / Documents and publications / The National Immunisation Programme in the Netherlands. Developments in 2009

RIVM Committed to health and sustainability
Menu